Besivance FDA Approval History
FDA Approved: Yes (First approved May 28, 2009)
Brand name: Besivance
Generic name: besifloxacin
Dosage form: Ophthalmic Suspension
Company: Bausch & Lomb
Treatment for: Conjunctivitis, Bacterial
Besivance (besifloxacin ophthalmic suspension) is a topical quinolone antimicrobial for the treatment of bacterial conjunctivitis, commonly referred to as "pink eye."
Development Timeline for Besivance
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.